Trial
NCT04001413
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
AstraZeneca
Condition
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Intervention
MEDI0457
Why stopped
Sponsor withdrew funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-29